TNPSC Thervupettagam
November 15 , 2020 1347 days 871 0
  • It is a mRNA-based Coronavirus vaccine candidate.
  • It has been found to be more than 90% effective in preventing the infection of COVID-19.
  • It is manufactured jointly by Pfizer (US-based pharma company) and BioNTech (German Biotech Company).

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories